Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
New England Journal of Medicine · 27.03.2025 · 392 (12) · 1178-1188
DOI: 10.1056/nejmoa2414482 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 27.03.2025. Verfasst von Brian J Lipworth und 19 weiteren Autor:innen. Beteiligte Einrichtung: Scottish Centre for Respiratory Research, and ENT Rhinology Clinic, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingd…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Nasal Polyps, Rhinosinusitis, Olfaction Disorders. Die Arbeit wurde bisher 231-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Amgen, AstraZeneca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Scottish Centre for Respiratory Research, and ENT Rhinology Clinic, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.
- Department of Otolaryngology, Head and Neck Surgery, Eastern Virginia Medical School, Norfolk.
- Division of Otolaryngology, Head and Neck Surgery, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal.
- Department of Otolaryngology-Head and Neck Surgery, Guy's and St. Thomas' Hospital, London.
- Division of Otolaryngology, Head and Neck Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston.
- Rhinology Unit and Smell Clinic, Department of Otorhinolaryngology, Hospital Clinic Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunyer, Centro de Investigación Biomédica en Red de Enfermedades Respira…
Förderung
- Amgen
- AstraZeneca
Zitieren
APA
Lipworth, B. J., Han, J. K., Desrosiers, M., Hopkins, C., Lee, S. E., Mullol, J., Pfaar, O., Li, T., Chen, C., Almqvist, G., Margolis, M. K., McLaren, J., Jagadeesh, S., MacKay, J., Megally, A., Hellqvist, Å., Mankad, V. S., Bahadori, L., Ponnarambil, S. S., & WAYPOINT Study Investigators (2025). Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps. New England Journal of Medicine, 392(12), 1178-1188. https://doi.org/10.1056/nejmoa2414482
Vancouver
Lipworth BJ, Han JK, Desrosiers M, Hopkins C, Lee SE, Mullol J, et al. Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps. New England Journal of Medicine. 2025;392(12):1178-1188. doi:10.1056/nejmoa2414482
BibTeX
@article{Lipworth2025,
author = {Lipworth, Brian J and Han, Joseph K and Desrosiers, Martin and Hopkins, Claire and Lee, Stella E and Mullol, Joaquim and Pfaar, Oliver and Li, Ting and Chen, Claudia and Almqvist, Gun and Margolis, Mary Kay and McLaren, Julie and Jagadeesh, Shankar and MacKay, Jamie and Megally, Ayman and Hellqvist, Åsa and Mankad, Vaishali S and Bahadori, Lila and Ponnarambil, Sandhia S and WAYPOINT Study Investigators, WAYPOINT Study Investigators},
title = {Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps},
journal = {New England Journal of Medicine},
year = {2025},
volume = {392},
number = {12},
pages = {1178--1188},
doi = {10.1056/nejmoa2414482}
}
EUVIMED